When was BigHat founded?

BigHat was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is BigHat located?

BigHat is headquartered in San Carlos, United States.

How many employees does BigHat have?

As of Aug 31, 2026, the latest employee count at BigHat is 96.

Is BigHat a funded company?

BigHat is a funded company, having raised a total of $223M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 19, 2019.

How much is BigHat worth?

The latest valuation of BigHat is $***** as of Jul 13, 2026.

When was the latest funding round of BigHat?

BigHat's latest funding was a $***** Series C round on Sep 24, 2026, with participation from 16 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.88B in funding in 2026 to date.

Where does BigHat rank among its competitors?

BigHat ranks 22nd amongst 210 active competitors, of which 64 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was BigHat, which secured $75M in Sep, 2026.

Who are the top competitors of BigHat?

BigHat's top competitors include argenx, Chai Discovery and Halozyme. Among them, BigHat secured the most recent funding round in September, 2026.

BigHat - 2026 Company Profile, Team, Funding & Competitors

BigHat is a series C company based in San Carlos (United States), founded in 2019 by Peyton Greenside. It operates as a Provider of antibody therapies developed by machine learning and synthetic biology. BigHat has raised $223M in funding from investors like Andreessen Horowitz, DFJ Growth and Premji Invest, with a current valuation of $*****. The company has 210 active competitors, including 64 funded and 63 that have exited. Its top competitors include companies like argenx, Chai Discovery and Halozyme.

Company Details

Provider of antibody therapies developed by machine learning and synthetic biology. The company offers an AI-enabled antibody design platform named Milliner, that offers antibody therapies to treat intractable conditions like chronic illnesses to life-threatening diseases.

Website: www.bighatbio.com/
Social
Email ID: *****@bighatbio.com

Key Metrics

Founded Year

2019

Location

San Carlos, United States

Stage

Series C

Total Funding

$223M in 4 rounds

Latest Funding Round

Series C, Sep 24, 2026, $*****

Post Money Valuation

$***** as on Jul 13, 2026

Investors

Andreessen Horowitz & 26 more

Ranked

22^nd among 210 active competitors

Employee Count

96 as on Aug 31, 2026

Investment & Acquisitions

Frugi

Similar Companies

argenx & 253 more

View BigHat's full profile

BigHat has raised a total funding of $223M over 4 rounds. Its first funding round was on Dec 19, 2019. Its latest funding round was a Series C round on Sep 24, 2026 for $*****. 16 investors participated in its latest round. BigHat has 27 institutional investors.

Here is the list of recent funding rounds of BigHat:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 24, 2026	4266060	Series C	8096642	8544731	1114186	9654985
Jun 30, 2022	6112288	Series B	2011746	8107351	6013707	Amgen Business Development & 7 more
Feb 10, 2021	2977871	Series A	5468474	1250165	Andreessen Horowitz	8VC & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of BigHat's funding rounds and investors

The founders of BigHat is Peyton Greenside.

Here are the details of BigHat's key team members:

Peyton Greenside: Co-founder and CSO of BigHat.
Contact Info: 1 email address

View details of BigHat's Founder profiles and Board Members

BigHat's employee count trend

BigHat has 96 employees as of Aug 26. Here is BigHat's employee count trend over the years:

Uncover BigHat's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BigHat include argenx, Chai Discovery and Halozyme. Here is the list of Top 10 competitors of BigHat, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	argenx 2008, Ghent (Belgium), Public	Developer of antibody-based drugs to treat autoimmune diseases and cancer	$61.9M	Life Sciences Partners, Seventure Partners ... & 21 others	75/100
2nd	Chai Discovery 2023, San Francisco (United States), Series C	Developer of artificial intelligence models for de novo molecular design	$630M	Kleiner Perkins, Oak HC/FT & 30 others	70/100
3rd	Halozyme 1999, San Diego (United States), Public	Developer of drug delivery technologies for the treatment of various diseases	-	Colt Ventures, BB Biotech & 8 others	67/100
4th	Zai Lab 2013, Shanghai (China), Public	Developer of drugs for anti-cancer and anti-inflammatory diseases	$160M	HongShan, Rock Springs Capital & 9 others	67/100
5th	Antiverse 2017, Cardiff (United Kingdom), Series A	Developer of computational platform for de novo design of antibody therapeutics	$20M	Kadmos Capital, Cambridge Angels & 34 others	67/100
6th	Alexion 1992, Zurich (Switzerland), Acquired	Developer of therapies for patients with devastating and rare diseases	$133M	Allen & Company, Invesco & 9 others	67/100
7th	XOMA Corporation 1981, Berkeley (United States), Acquired	Developer of antibody-based therapeutics for treating endocrine/metabolic diseases	-	Ignite 500, Hercules Capital & 5 others	65/100
8th	Kodiak Sciences 2009, Palo Alto (United States), Public	Developer of therapeutics to treat retinal diseases	$35.8M	ArrowMark Partners, Perceptive Advisors & 1 others	64/100
9th	ABL Bio 2016, Seongnam-si (South Korea), Public	Bi-specific antibodies and Antibody-drug Conjugate immunotherapies for oncology and neurodegenerative diseases	$65M	QUAD, Hana Financial Group & 7 others	63/100
10th	MacroGenics 2000, Rockville (United States), Public	Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease	$126M	Nextech Venture, Ventures West & 29 others	62/100
22nd	BigHat 2019, San Carlos (United States), Series C	Provider of antibody therapies developed by machine learning and synthetic biology	$223M	Amgen Business Development, AME Cloud Ventures ... & 25 others	58/100